Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Monetary Value of Quality-Adjusted Life Years (Qaly) Among Patients With Cardiovascular Disease: A Willingness to Pay Study (Wtp)
Akbar Abdollahi-Asl
Akbar Abdollahi-Asl

Associate Professor of Pharmacoeconomics and Pharmaceutical Administration

Department Pharmacoeconomics and Pharmaceutical Administration

School of Pharmacy

Pharmaceutical Management & Economics Research Center

Tehran University of Medical Sciences

Related Documents
1. Eliciting the Public Preferences for Pharmaceutical Subsidy in Iran: A Discrete Choice Experiment Study, Journal of Pharmaceutical Policy and Practice (2021)
All Documents
1. Exploring the Financial Burden of Pediatric Bone Marrow Transplantation: A Cross-Sectional Study From the Caregiver’S Viewpoint, BMC Health Services Research (2025)
2. Age- and Gender-Specific Acute Poisoning With Drugs and Medications Affecting Nervous System, BMC Pharmacology and Toxicology (2024)
3. Choosing the Best Instrument for Measuring Health Spillover Effect in Caregivers of Patients With Multiple Sclerosis, Value in Health Regional Issues (2024)
4. Risk Assessment for Complex Systems Based on Fuzzy Cognitive Maps: A Case of the Biopharmaceutical Industry, Complexity (2024)
5. Systematic Review of Patient Preference Studies in Non-Metastatic Breast Cancer Adjuvant Medication Therapy: Attribute Selection, Iranian Journal of Pharmaceutical Research (2024)
6. Systematic Review of Patient Preference Studies in Non-Metastatic Breast Cancer Adjuvant Medication Therapy: Attribute Selection, Iranian Journal of Pharmaceutical Research (2024)
7. Towards Greater Impact in Health Technology Assessment: System Dynamic Approach for New and Emerging Technologies in Iran, DARU# Journal of Pharmaceutical Sciences (2024)
8. Assessment of Influential Variables in the Pricing of Locally Manufactured Pharmaceuticals: Current Challenging Situation in Iran, Iranian Journal of Pharmaceutical Research (2021)
9. Correction To: Eliciting the Public Preferences for Pharmaceutical Subsidy in Iran: A Discrete Choice Experiment Study (Journal of Pharmaceutical Policy and Practice, (2021), 14, 1, (59), 10.1186/S40545-021-00345-4), Journal of Pharmaceutical Policy and Practice (2021)
10. Eliciting the Public Preferences for Pharmaceutical Subsidy in Iran: A Discrete Choice Experiment Study, Journal of Pharmaceutical Policy and Practice (2021)
11. Factors Affecting Tendency and Adherence to Traditional Persian Medicine: A Qualitative Study, Jundishapur Journal of Natural Pharmaceutical Products (2021)
12. Pharmaceutical Subsidy Policy in Iran: A Qualitative Stakeholder Analysis, Health Research Policy and Systems (2021)
13. Risk Factors of Supply Chain in Biopharmaceutical Companies in Iran, Pharmaceutical Sciences (2021)
14. Trend Analysis of Anti-Allergic Medicines During the 11-Year Period in Iran (2006-2017), Acta Medica Iranica (2021)
15. Why Healthcare Market Needs Government Intervention to Improve Access to Essential Medicines and Healthcare Efficiency: A Scoping Review From Pharmaceutical Price Regulation Perspective, Journal of Pharmaceutical Health Services Research (2020)
16. Availability, Pricing and Affordability of Selected Medicines for Noncommunicable Diseases; [Disponibilite, Prix Et Accessibilite Economique D’Une Selection De Medicaments Pour La Prise En Charge Des Maladies Non Transmissibles], Eastern Mediterranean Health Journal (2019)
17. Healthcare Resource Utilization and the Cost of Care for Mps-I Patients in Iran, Value in Health Regional Issues (2019)